1. Akard LP, Brandt J, Lu L, Jansen J, Hoffman R (1987) Chronic T cell lymphoproliferative disorder and pure red cell aplasia. Further characterization of cell-mediated inhibition of erythropoiesis and clinical response to cytotoxic chemotherapy. Am J Med 83: 1069
2. Awwad M, North RJ (1988) Cyclophosphamide (CY)-facilitated adoptive immunotherapy of a CY-resistant tumor. Evidence of adoptive T-cell mediated immunity by removing suppressor T cell rather than by reducing tumor burden. Immunology 65: 87
3. Awwad M, North RJ (1989) Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res 49: 1649
4. Ballas ZK (1986) Lymphokine-activated killer (LAK) cells. J Immunol 137: 2380
5. Carter RH, Drebin JA, Schatten S, Perry LL, Greene MI (1983) Regulation of the immune response to tumor antigens: IX. In vitro Lyt-1+2− cell proliferative responses to cellbound or subcellular tumor antigen. J Immunol 130: 997